📣 VC round data is live. Check it out!

Meinian Onehealth Valuation Multiples

Discover Meinian Onehealth's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like Global Health, Concentra Group, Option Care Health, Medicover and more.

Meinian Onehealth Overview

About Meinian Onehealth

Meinian Onehealth Healthcare Holdings Co Ltd is engaged in the provision of physical examination and medical services. The firm provides health consultation, and health assessment services among others.


Founded

2004

HQ

China

Employees

2.1K

Financials (LTM)

Revenue: $2B
EBITDA: $286M

EV

$4B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Meinian Onehealth Financials

Meinian Onehealth reported last 12-month revenue of $2B and EBITDA of $286M.

In the same LTM period, Meinian Onehealth generated $641M in gross profit, $286M in EBITDA, and $50M in net income.

Revenue (LTM)


Meinian Onehealth P&L

In the most recent fiscal year, Meinian Onehealth reported revenue of $2B and EBITDA of $322M.

Meinian Onehealth is profitable as of last fiscal year, with gross margin of 41%, EBITDA margin of 21%, and net margin of 3%.

See analyst estimates for Meinian Onehealth
LTMLast FY202320242025202620272028
Revenue$2B$2B$2B$2B$2B
Gross Profit$641M$633M$689M$677M$633M
Gross Margin41%41%43%43%41%
EBITDA$286M$322M$348M$316M$304M
EBITDA Margin19%21%22%20%20%
EBIT Margin7%10%11%10%10%
Net Profit$50M$42M$75M$42M$42M
Net Margin3%3%5%3%3%

Financial data powered by Morningstar, Inc.

Meinian Onehealth Stock Performance

Meinian Onehealth has current market cap of $3B, and enterprise value of $4B.

Market Cap Evolution


Meinian Onehealth's stock price is $0.84.

Meinian Onehealth share price increased by 0.4% in the last 30 days, and by 12.9% in the last year.

Meinian Onehealth has an EPS (earnings per share) of $0.01.

See more trading valuation data for Meinian Onehealth
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$4B$3B0.4%0.4%2.0%12.9%$0.01

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Meinian Onehealth Valuation Multiples

Meinian Onehealth trades at 2.4x EV/Revenue multiple, and 13.2x EV/EBITDA.

See NTM and 2027E valuation multiples for Meinian Onehealth

EV / Revenue (LTM)


Meinian Onehealth Financial Valuation Multiples

As of June 2, 2026, Meinian Onehealth has market cap of $3B and EV of $4B.

Meinian Onehealth has a P/E ratio of 65.7x.

LTMLast FY202320242025202620272028
EV/Revenue2.4x2.5x2.4x2.4x2.5x
EV/EBITDA13.2x11.8x10.9x12.0x12.4x
EV/EBIT35.8x24.4x21.0x23.1x24.4x
EV/Gross Profit5.9x6.0x5.5x5.6x6.0x
P/E65.7x78.2x44.1x79.1x78.2x
EV/FCF-18.6x15.9x21.1x18.6x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Meinian Onehealth Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Meinian Onehealth Margins & Growth Rates

Meinian Onehealth grew revenue by 4% but EBITDA decreased by 26% in the last fiscal year.

In the most recent fiscal year, Meinian Onehealth reported gross margin of 41%, EBITDA margin of 21%, and net margin of 3%.

See estimated margins and future growth rates for Meinian Onehealth

Meinian Onehealth Margins

Last FY202420252026202720282029
Gross Margin41%43%41%42%
EBITDA Margin21%20%20%15%
EBIT Margin10%10%10%7%
Net Margin3%3%3%4%
FCF Margin13%11%13%-

Meinian Onehealth Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth4%(2%)(3%)4%
Gross Profit Growth4%(2%)(6%)4%
EBITDA Growth(26%)(9%)(4%)(22%)
EBIT Growth(24%)(9%)(5%)(24%)
Net Profit Growth47%(44%)1%47%
FCF Growth-(25%)14%-

Data powered by FactSet, Inc. and Morningstar, Inc.

Meinian Onehealth Operational KPIs

Meinian Onehealth's revenue per employee in the last FY averaged $0.7M, while opex per employee averaged $0.2M for the same period.

Meinian Onehealth's Rule of 40 is 18% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Meinian Onehealth's Rule of X is 24% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Meinian Onehealth
LTMLast FY202320242025202620272028
Rule of 4023%18%---
Bessemer Rule of X30%24%---
Revenue per Employee-$0.7M---
Opex per Employee-$0.2M---
S&M Expenses to Revenue23%22%5%6%6%
G&A Expenses to Revenue8%8%2%3%3%
R&D Expenses to Revenue1%1%1%1%1%
Opex to Revenue-31%32%32%31%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Meinian Onehealth Competitors

Meinian Onehealth competitors include Global Health, Concentra Group, Option Care Health, Medicover, Krishna Institute, Asker Healthcare Group, Mouwasat, LifeStance Health, Kpj Healthcare and IKS Health.

Most Meinian Onehealth public comparables operate across Hospitals & Clinics.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Global Health7.1x7.0x30.9x32.8x
Concentra Group2.4x2.4x12.3x11.8x
Option Care Health0.8x0.8x9.1x9.1x
Medicover1.8x1.7x10.9x10.4x
Krishna Institute8.8x8.4x41.8x40.5x
Asker Healthcare Group2.1x2.0x17.6x16.7x
Mouwasat4.2x4.0x11.9x12.0x
LifeStance Health2.3x2.2x20.9x18.3x

This data is available for Pro users. Sign up to see all Meinian Onehealth competitors and their valuation data.

Start Free Trial

Meinian Onehealth VC Funding History

Before going public, Meinian Onehealth raised $49M in total equity funding, across 1 round.


Meinian Onehealth Funding Rounds

DateStageRaised FromRaisedValuationRev. MultipleDeal Summary
Sep-13Undisclosed stageCathay Capital Private Equity; Ping An Ventures; Carlyle Group$49M-The Carlyle Group, Ping An Insurance Company of China, and Cathay Capital Private Equity jointly invested RMB300 million (approximately US$48.6 million) in a Series B financing round for Health 100, a China-based health examination service provider, announced on 2 September 2013. The transaction was structured through The Carlyle Group's RMB fund Beijing Carlyle Investment Centre and Cathay Capital Private Equity's Sino French Fund. The Carlyle Group had previously acquired a 13.5 percent stake in Health 100, formerly known as Meinian Onehealth Healthcare, in August 2012. The company intended to use the new Series B financing to develop its service offerings. However, the post-money valuation of Health 100 following this round, revenue figures, EBITDA, and valuation multiples were not disclosed in available public sources.

Acquisitions by Meinian Onehealth

Meinian Onehealth has acquired 1 company to date.

Last acquisition by Meinian Onehealth was on June 14th 2017. Meinian Onehealth acquired Ciming Checkup for $7M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Meinian Onehealth

Ciming Checkup
Description
Ciming Checkup is a Beijing-based preventive healthcare provider operating China's first dedicated health examination centers since 1993. Services include physical checkups, private physician consultations, digital health tracking, medical referrals, and insurance products under sub-brands like Ciming Physical Examination and Aoya International Medical Club. It runs 50 centers in 20 cities serving millions annually.
HQ CountryChina
HQ City
Beijing
Deal Date14 Jun 2017
Valuation$7M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Meinian Onehealth acquisitions and their M&A valuation multiples.

Start Free Trial

Investments by Meinian Onehealth

Meinian Onehealth has invested in 5 companies to date.

Latest investment by Meinian Onehealth was on June 29th 2020. Meinian Onehealth invested in CapitalBio Technology in their $113M Series C round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Meinian Onehealth

CapitalBio Technology
Zhangshang Tangyi
Mega Genomics
SHENZHEN OASIS HEALTH MANAGEMENT
Description
CapitalBio Technology is a life sciences company commercializing microarray and microfluidic technologies for research, diagnostics, and biosafety. Beijing-headquartered in the Economic-Technological Development Area since 2012, it operates as a core subsidiary of CapitalBio Corporation and the Biological Chip Beijing National Engineering Research Center. The firm supplies chips, instruments, reagents, and software to biomedical researchers and healthcare professionals worldwide.
Zhangshang Tangyi is a health management platform in China focused on diabetes care. Hangzhou-based and founded in 2014, it allows patients to upload glucose readings via apps, receiving doctor guidance. The platform connects 100,000 users with 5,000 physicians across Zhejiang province.
Mega Genomics Ltd is a genetic testing platform company in China with a focus on consumer genetic testing and cancer screening services. The company has launched dozens of testing services, covering a wide range of fields such as nutrition and metabolism, cancer risk assessment, chronic disease susceptibility, cancer screening, and infectious disease diagnosis, to meet consumers growing preventive medical needs. It generates a majority of its revenue from consumer genetic testing services.
SHENZHEN OASIS HEALTH MANAGEMENT is a Shenzhen-based clinic offering internal medicine, surgery, otolaryngology, stomatology, liver and renal function tests, blood routines, color Doppler ultrasounds, cancer screenings, MRI, CT scans, capsule gastroscopy. Services extend to genetic testing, chronic disease management, telemedicine, women's health, corporate wellness via szaoya.com.
HQ CountryChinaChinaChinaChina
HQ City
Beijing
Hangzhou
-
Shenzhen
Deal Date29 Jun 20207 Jan 201911 May 201819 Dec 2017
RoundSeries CSeries CUndisclosed stageSeries A
Raised$113M$100M$61M$2M
InvestorsFriend Capital; Guangdong Boyi Jianzhu Shejiyuan; Meinian Onehealth; Hongma Investment; Huzhou Jiasi Enterprise Consulting Service Office; Lianxing Capital; Meinian Onehealth; New Alliance Capital; Red Horse Capital; Sinopec Capital; Suzhou Youcai Huiying Investment Center; TusholdingsChina Capital Investment Group; CICC; Meinian Onehealth; IDG Capital; LB Investment; Ping An Ventures; Samsung Ventures; Tasly PharmaceuticalMeinian OnehealthMeinian Onehealth; Tianyi Group
Valuationundisclosedundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Meinian Onehealth investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Meinian Onehealth

When was Meinian Onehealth founded?Meinian Onehealth was founded in 2004.
Where is Meinian Onehealth headquartered?Meinian Onehealth is headquartered in China.
How many employees does Meinian Onehealth have?As of today, Meinian Onehealth has over 2K employees.
Is Meinian Onehealth publicly listed?Yes, Meinian Onehealth is a public company listed on Shenzhen Stock Exchange.
What is the stock symbol of Meinian Onehealth?Meinian Onehealth trades under 002044 ticker.
When did Meinian Onehealth go public?Meinian Onehealth went public in 2005.
Who are competitors of Meinian Onehealth?Meinian Onehealth main competitors include Global Health, Concentra Group, Option Care Health, Medicover, Krishna Institute, Asker Healthcare Group, Mouwasat, LifeStance Health, Kpj Healthcare, IKS Health.
What is the current market cap of Meinian Onehealth?Meinian Onehealth's current market cap is $3B.
What is the current revenue of Meinian Onehealth?Meinian Onehealth's last 12 months revenue is $2B.
What is the current revenue growth of Meinian Onehealth?Meinian Onehealth revenue growth (NTM/LTM) is 5%.
What is the current EV/Revenue multiple of Meinian Onehealth?Current revenue multiple of Meinian Onehealth is 2.4x.
What is the current EBITDA of Meinian Onehealth?Meinian Onehealth's last 12 months EBITDA is $286M.
What is Meinian Onehealth's EBITDA margin?Meinian Onehealth's last 12 months EBITDA margin is 19%.
What is the current EV/EBITDA multiple of Meinian Onehealth?Current EBITDA multiple of Meinian Onehealth is 13.2x.
How many companies Meinian Onehealth has acquired to date?As of June 2026, Meinian Onehealth has acquired 1 company.
What was the largest acquisition by Meinian Onehealth?$7M acquisition of Ciming Checkup on 14th June 2017 was the largest M&A Meinian Onehealth has done to date.
What companies Meinian Onehealth acquired?Meinian Onehealth acquired Ciming Checkup.
In how many companies Meinian Onehealth has invested to date?As of June 2026, Meinian Onehealth has invested in 5 companies.
What was the last Meinian Onehealth investment?On 29th June 2020 Meinian Onehealth invested in CapitalBio Technology, participating in a $113M Series C round, alongside Friend Capital, Guangdong Boyi Jianzhu Shejiyuan, Hongma Investment, Huzhou Jiasi Enterprise Consulting Service Office, Lianxing Capital, New Alliance Capital, Red Horse Capital, Sinopec Capital, Suzhou Youcai Huiying Investment Center, and Tusholdings.
In what companies Meinian Onehealth invested in?Meinian Onehealth invested in CapitalBio Technology, Zhangshang Tangyi, Mega Genomics, Vedeng, and SHENZHEN OASIS HEALTH MANAGEMENT.

See public comps similar to Meinian Onehealth

Lists including Meinian Onehealth

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial